Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
A Look At Regencell Bioscience Holdings (RGC) Valuation After A US$500 Million At The Market Offering
Regencell Bioscience Holdings (RGC) has filed for a US$500 million at-the-market offering, highlighting potential dilution for shareholders. Despite a significant one-year return, the stock has recently declined, and its Price-to-Book ratio of 2,373.6x is substantially higher than industry and peer averages, indicating a focus on future potential rather than current financial performance, as the company operates with no revenue and ongoing losses. This high valuation, coupled with the lack of revenue and losses, suggests the stock could be vulnerable to setbacks.